Category: Actemra/RoActemra - Medicine Pharmacy Nutrition

Roche’s Actemra/RoActemra (tocilizumab) Fails to Meet the Primary Endpoint in P-III COVACTA Study for Patients with COVID-19 Associated Pneumonia

July 29, 2020 Auto Bot 0

Shots: The P-III COVACTA study involves assessing of Actemra/RoActemra (IV) + SOC vs PBO + SOC in adult patients hospitalized with severe COVID-19 associated pneumonia. […]

Copyright © 2022 | WordPress Theme by MH Themes

Azərbaycan dili

Беларуская мова

বাংলা

Български

ქართული

Ελληνικά

ગુજરાતી

Ōlelo Hawaiʻi

עִבְרִית

हिन्दी

Bahasa Indonesia

ಕನ್ನಡ

Қазақ тілі

ភាសាខ្មែរ

Кыргызча

ພາສາລາວ

Latviešu valoda

Lietuvių kalba

Lëtzebuergesch

Македонски јазик

മലയാളം

मराठी

ဗမာစာ

नेपाली

ਪੰਜਾਬੀ

Српски језик

සිංහල

தமிழ்

తెలుగు

Українська